To compare analgesic effect of two different doses of intrathecal nalbuphine (0.8 mg versus 1.6mg) as an adjuvant to 0.75% isobaric ropivacaine along with control group for elective lower limb surgeries
- Conditions
- Health Condition 1: M849- Disorder of continuity of bone, unspecified
- Registration Number
- CTRI/2022/03/040896
- Lead Sponsor
- Sawai Man Singh medical college and atttached hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patient of either sex.
Age group between 18 to 60 years.
Weight of the patient between 40-70 kilograms.
Height of the patient >= 145cm.
Patients belonging to ASA class I and II.
Patients undergoing elective lower limb surgery.
Patientâ??s refusal for spinal anaesthesia.
Uncooperative patients.
Patients not willing to participate in the study.
Patients with compromised airway or morbid obesity.
Patients with contraindications for spinal anesthesia.
History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit.
Patients with history of hypertension, diabetes mallietus, respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above).
Pregnant patients.
Patient receiving phenothiazine, hypnotics or other central nervous system depressants.
•Patients in which spinal anesthesia failed.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method